Log In
Print this Print this

Ezutromid F6

  Manage Alerts
Collapse Summary General Information
Company Summit Therapeutics plc
DescriptionOptimized formulation of ezutromid, a small molecule utrophin (UTRN) modulator
Molecular Target Utrophin (UTRN)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today